ERIC SEMLER, Board Member at Semler Scientific (NASDAQ:SMLR), reported acquisition of company stock options on May 29, according to a new SEC filing.
What Happened: In a Form 4 filing with the U.S. Securities and Exchange Commission on Wednesday, SEMLER, Board Member at Semler Scientific, acquired stock options for 27,000 shares of SMLR. These options provide SEMLER with the right to purchase the company's stock at $23.32 per share.
During Thursday's morning session, Semler Scientific shares up by 3.13%, currently priced at $33.25. Considering the current price, SEMLER's 27,000 shares have a total value of $268,110.
All You Need to Know About Semler Scientific
Semler Scientific Inc is a United States based company that is engaged in providing technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. It focuses on developing, manufacturing, and marketing proprietary products and services that assist customers, including insurance plans, physicians, and risk assessment groups, in evaluating and treating chronic diseases. The company markets its vascular-testing product under the QuantaFlo brand, which is a four-minute in-office blood flow test.
Semler Scientific: Financial Performance Dissected
Revenue Growth: Semler Scientific's revenue growth over a period of 3 months has faced challenges. As of 31 March, 2024, the company ...